Core Peptides
20 mg vial
- Vendor score
- 80/100
- Effective vial price
- $68
- Effective price per mg
- $3.40
Bronchogen is a short-peptide product commonly placed in the bioregulator category.
Also known as bronchogen
Research shortlist · Sep 12, 2026
These research selections use the same basis: 20 mg vial. The selections remain from Sep 12, 2026; each price below comes from its dated market observation.
20 mg vial
20 mg vial
20 mg vial
What it is
PubChem identifies the record as Bronchogen. The listed molecular formula is C18H30N4O9. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
1 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
Bronchogen is commonly sold or discussed for organ-specific bioregulator research and general wellness goals. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Same format. Same amount.
2 of 2 formats had a qualifying research shortlist on Sep 12, 2026. Vendor counts below reflect the available price observations.
Vendor directory
Grades describe the vendor record overall. They are not a test result for every product.
| Vendor | Grade | Compared offers | In stock when checked | Lowest effective package | Profile |
|---|---|---|---|---|---|
| EZ PeptidesVendor grade | Grade A- | 1 | 1 | $52.20Automatic buy x get y free · listed $5810 mg vial · compare →Observed Sep 21, 2026 | View → |
| Ameano PeptidesVendor grade | Grade B+ | 1 | 1 | $5810 mg vial · compare →Observed Sep 21, 2026 | View → |
| Core PeptidesVendor grade | Grade B+ | 1 | 1 | $6820 mg vial · compare →Observed Sep 21, 2026 | View → |
| Biolongevity LabsVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Ion PeptidesVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Swiss ChemsVendor grade | Grade C | 1 | 1 | $64.9520 mg vial · compare →Observed Sep 21, 2026 | View → |
| AIO PeptidesNot enough information to grade | Not enough information to grade | 1 | 1 | $51.20Automatic percent off · listed $6420 mg vial · compare →Observed Sep 21, 2026 | View → |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.